Your search returned 9 results.

Results
	1.	Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study. MedStar authors: Calhoun, Darren Howard, Barbara V Shara, Nawar M Umans, Jason G Wang, Hong PMID: 21788631 Year: 2011 Citation: Diabetes Care. 34(9):1952-8, 2011 Sep. Institution: MedStar Health Research Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Calhoun D, de Simone G, Devereux R, Howard BV, Lee ET, Shara NM, Umans JG, Wang H DOI: http://dx.doi.org/10.2337/dc11-0329 Add to cart (remove)
	2.	Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. MedStar authors: Aroda, Vanita R Fernandez, Stephen J Ratner, Robert E PMID: 23305087 Year: 2013 Citation: Diabetes Technology & Therapeutics. 15(2):117-23, 2013 Feb. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Aroda VR, Conway BN, Fernandez SJ, Matter NI, Maynard JD, Orchard TJ, Ratner RE DOI: http://dx.doi.org/10.1089/dia.2012.0211 Add to cart (remove)
	3.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27284114 Year: 2016 Citation: Diabetes Care. 39(9):1579-86, 2016 Sep Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T DOI: https://dx.doi.org/10.2337/dc16-0046 Add to cart (remove)
	4.	The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. MedStar authors: Masden, Derek PMID: 23783058 Year: 2013 Citation: Plastic & Reconstructive Surgery. 132(4):996-1004, 2013 Oct. Institution: Curtis National Hand Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Attinger C, Endara M, Goldstein J, Gondek S, Masden D, Steinberg J DOI: http://dx.doi.org/10.1097/PRS.0b013e31829fe119 Add to cart (remove)
	5.	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors: Ratner, Robert E PMID: 24650952 Year: 2014 Citation: Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T DOI: http://dx.doi.org/10.1016/j.jdiacomp.2014.01.012 Add to cart (remove)
	6.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27650977 Year: 2016 Citation: Diabetes Care. 39(11):1972-1980, 2016 Nov Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C DOI: https://dx.doi.org/10.2337/dc16-1495 Add to cart (remove)
	7.	Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors: Aroda, Vanita R PMID: 26990378 Year: 2016 Citation: Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J DOI: https://dx.doi.org/10.1111/dom.12661 Add to cart (remove)
	8.	Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors: Fatemi, Omid Yuriditsky, Eugene PMID: 25159234 Citation: American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E DOI: http://dx.doi.org/10.1016/j.amjcard.2014.07.045 Add to cart (remove)
	9.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)

Powered by Koha